Trials / Completed
CompletedNCT01190631
An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) Implantation
An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation After SN60WF IOL Implantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate total residual spherical aberration (TSA) post-IOL implantation, and to determine if an association exists between TSA, postoperative high order aberrations (HOA), and functional vision following IOL implantation in patients grouped by pre-operative corneal spherical aberration (CSA).
Detailed description
Patients will be grouped by pre-operative corneal spherical aberration (CSA) measures, i.e., ≤0.230 micron and ≥0.270 micron.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acrysof IQ (SN60WF) IOL | Acrysof IQ (SN60WF) intraocular lens implanted in the capsular bag of the eye during cataract surgery. The IOL is intended for the lifetime of the patient. Unilateral (one eye only) implantation is planned. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-11-01
- First posted
- 2010-08-27
- Last updated
- 2012-11-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01190631. Inclusion in this directory is not an endorsement.